{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:32:46Z","timestamp":1788820366109,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008518","name":"University of Texas Medical School at Houston","doi-asserted-by":"publisher","award":["New Faculty Start-up funds"],"award-info":[{"award-number":["New Faculty Start-up funds"]}],"id":[{"id":"10.13039\/100008518","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Science Foundation","award":["1916894"],"award-info":[{"award-number":["1916894"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R01NS117606-01A1"],"award-info":[{"award-number":["1R01NS117606-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cell specific-targeted therapy (CSTT) for acute ischemic stroke remains underdeveloped. Cerebrovascular endothelial cells (CECs) are key components of the blood\u2013brain barrier and are the first brain cells affected by ischemic stroke. After stroke, CEC injury causes insufficient energy supply to neurons and leads to cytotoxic and vasogenic brain edema. Aptamers are short single-stranded RNA or DNA molecules that can bind to specific ligands for cell specific delivery. The expression of vascular cell adhesion molecule-1 (VCAM-1) is increased on CECs after stroke. Herein, we report that an RNA-based VCAM-1-aptamer can specifically target CECs in stroke brains following transient middle cerebral artery occlusion in mice. Our data demonstrate the potential of an RNA-based aptamer as an effective delivery platform to target CECs after stroke. We believe this method will allow for the development of CSTT for treatment of patients with stroke.<\/jats:p>","DOI":"10.1038\/s41598-023-36993-6","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T09:02:01Z","timestamp":1687251721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A novel specific aptamer targets cerebrovascular endothelial cells after ischemic stroke"],"prefix":"10.1038","volume":"13","author":[{"given":"Heng","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Gusdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimahn A.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang Sophie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"36993_CR1","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1038\/s41467-020-17930-x","volume":"11","author":"X Ren","year":"2020","unstructured":"Ren, X., Hu, H., Farooqi, I. & Simpkins, J. W. Blood substitution therapy rescues the brain of mice from ischemic damage. Nat. Commun. 11, 4078. https:\/\/doi.org\/10.1038\/s41467-020-17930-x (2020).","journal-title":"Nat. Commun."},{"key":"36993_CR2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/STROKEAHA.110.586156","volume":"41","author":"V Hachinski","year":"2010","unstructured":"Hachinski, V. et al. Stroke: Working toward a prioritized world agenda. Stroke 41, 1084\u20131099. https:\/\/doi.org\/10.1161\/STROKEAHA.110.586156 (2010).","journal-title":"Stroke"},{"key":"36993_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/0256-4947.83217","volume":"31","author":"V Supanc","year":"2011","unstructured":"Supanc, V., Biloglav, Z., Kes, V. B. & Demarin, V. Role of cell adhesion molecules in acute ischemic stroke. Ann. Saudi Med. 31, 365\u2013370. https:\/\/doi.org\/10.4103\/0256-4947.83217 (2011).","journal-title":"Ann. Saudi Med."},{"key":"36993_CR4","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1161\/STROKEAHA.115.009099","volume":"46","author":"DN Doll","year":"2015","unstructured":"Doll, D. N. et al. Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier. Stroke 46, 1681\u20131689. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009099 (2015).","journal-title":"Stroke"},{"key":"36993_CR5","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1038\/emm.2016.44","volume":"48","author":"H Jo","year":"2016","unstructured":"Jo, H. & Ban, C. Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools. Exp. Mol. Med. 48, e230. https:\/\/doi.org\/10.1038\/emm.2016.44 (2016).","journal-title":"Exp. Mol. Med."},{"key":"36993_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J Zhou","year":"2017","unstructured":"Zhou, J. & Rossi, J. Aptamers as targeted therapeutics: Current potential and challenges. Nat. Rev. Drug Discov. 16, 181\u2013202. https:\/\/doi.org\/10.1038\/nrd.2016.199 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"36993_CR7","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.1161\/STROKEAHA.121.034910","volume":"52","author":"BAA Franx","year":"2021","unstructured":"Franx, B. A. A. et al. Molecular magnetic resonance imaging of vascular inflammation after recanalization in a rat ischemic stroke model. Stroke 52, e788\u2013e791. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034910 (2021).","journal-title":"Stroke"},{"key":"36993_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.jcbfm.9600198","volume":"26","author":"C Justicia","year":"2006","unstructured":"Justicia, C. et al. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J. Cereb. Blood Flow Metab. 26, 421\u2013432. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600198 (2006).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"36993_CR9","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.bmcl.2007.09.046","volume":"17","author":"F Chauveau","year":"2007","unstructured":"Chauveau, F. et al. Binding of an aptamer to the N-terminal fragment of VCAM-1. Bioorg. Med. Chem. Lett. 17, 6119\u20136122. https:\/\/doi.org\/10.1016\/j.bmcl.2007.09.046 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"36993_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/10_2020_124","volume":"174","author":"A Eilers","year":"2020","unstructured":"Eilers, A., Witt, S. & Walter, J. Aptamer-modified nanoparticles in medical applications. Adv. Biochem. Eng. Biotechnol. 174, 161\u2013193. https:\/\/doi.org\/10.1007\/10_2020_124 (2020).","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"36993_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1158\/1078-0432.CCR-18-1889","volume":"25","author":"VWT Cheng","year":"2019","unstructured":"Cheng, V. W. T. et al. VCAM-1-targeted MRI enables detection of brain micrometastases from different primary tumors. Clin. Cancer Res. 25, 533\u2013543. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1889 (2019).","journal-title":"Clin. Cancer Res."},{"key":"36993_CR12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1089\/ars.2010.3522","volume":"15","author":"JM Cook-Mills","year":"2011","unstructured":"Cook-Mills, J. M., Marchese, M. E. & Abdala-Valencia, H. Vascular cell adhesion molecule-1 expression and signaling during disease: Regulation by reactive oxygen species and antioxidants. Antioxid. Redox Signal. 15, 1607\u20131638. https:\/\/doi.org\/10.1089\/ars.2010.3522 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"36993_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1083\/jcb.125.1.215","volume":"125","author":"RH Vonderheide","year":"1994","unstructured":"Vonderheide, R. H., Tedder, T. F., Springer, T. A. & Staunton, D. E. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J. Cell Biol. 125, 215\u2013222. https:\/\/doi.org\/10.1083\/jcb.125.1.215 (1994).","journal-title":"J. Cell Biol."},{"key":"36993_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jnen\/61.6.539","volume":"61","author":"JW Peterson","year":"2002","unstructured":"Peterson, J. W. et al. VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 61, 539\u2013546. https:\/\/doi.org\/10.1093\/jnen\/61.6.539 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"36993_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/neur.2021.0007","volume":"2","author":"HE Hinson","year":"2021","unstructured":"Hinson, H. E. et al. Antibody-free mass spectrometry identification of vascular integrity markers in major trauma. Neurotrauma Rep. 2, 322\u2013329. https:\/\/doi.org\/10.1089\/neur.2021.0007 (2021).","journal-title":"Neurotrauma Rep."},{"key":"36993_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041057","author":"DH Kong","year":"2018","unstructured":"Kong, D. H., Kim, Y. K., Kim, M. R., Jang, J. H. & Lee, S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19041057 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"36993_CR17","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1038\/s41598-020-59997-y","volume":"10","author":"H Hu","year":"2020","unstructured":"Hu, H. et al. MiR-34a interacts with cytochrome c and shapes stroke outcomes. Sci. Rep. 10, 3233. https:\/\/doi.org\/10.1038\/s41598-020-59997-y (2020).","journal-title":"Sci. Rep."},{"key":"36993_CR18","first-page":"10","volume":"6","author":"M McKeague","year":"2022","unstructured":"McKeague, M. et al. The minimum aptamer publication standards (MAPS guidelines) for de novo aptamer selection. Aptamers 6, 10\u201318 (2022).","journal-title":"Aptamers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36993-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:14:27Z","timestamp":1687256067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36993-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36993"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36993-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"24 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9990"}}